发明名称 NOBEL COMPOUNDS HAVING SELECTIVE INHIBITING EFECT AT GSK3.
摘要 <p>The present invention relates to new compounds of formula (I) wherein Z is N; Y is CONR5, NR5CO, SO2NR5, NR5SO2, CH2NR5, NR5, NR5CONR5, CH2CO, CO, O or CH2O; X is CH or N; P is phenyl or a 5 or 6 membered heteroaromatic ring containing one or more heteroatoms selected from N, O or S and said phenyl ring or 5 or 6 membered heteroaromatic ring may optionally be fused with a 5 or 6 membered saturated, partially saturated or unsaturated ring containing one or more atoms selected from C, N, O or S; Q is C1-6alkyl, C2-6alkenyl or C2-6alkynyl, a process for their preparation and new intermediates used therein, pharmaceutical formulations containing said therapeutically active compounds and to the use of said active compounds in therapy, such as provide compounds having a selective inhibiting effect at GSK3.</p>
申请公布号 MXPA05006244(A) 申请公布日期 2005.08.19
申请号 MX2005PA06244 申请日期 2003.12.15
申请人 ASTRAZENECA AB 发明人 PETER SOEDERMAN
分类号 A61P3/10;A61P5/48;A61P15/18;A61P17/14;A61P25/00;C07D241/26;C07D403/06;C07D409/06;(IPC1-7):A61K31/496;C07D413/14;A61K31/497;A61K31/537;C07D403/14;C07D403/12;C07D401/14;C07D401/12 主分类号 A61P3/10
代理机构 代理人
主权项
地址